LBA50 Perioperative nivolumab (NIVO) v placebo (PBO) in patients (pts) with resectable NSCLC: Clinical update from the phase III CheckMate 77T study

M. Provencio Pulla, Mark M. Awad, Tina Cascone, J.D. Spicer, Jie He, Shun Lü, Aurelia Alexandru, Y. Watanabe, Robin Cornelissen, L.D.O. Koch, J. Kuzdzal, J-L. Pujol, P. Hoffknecht, Jhanelle E. Gray, C. Coronado Erdmann, J. Neely, V. Devas, Simi Bhatia, Fumihiro Tanaka